Google rolls out Loss of Pulse Detection to the Pixel Watch 3 in the US after getting FDA clearance in February 2025; the feature rolled out in Europe in 2024
Following the April 2025 OTA update and Scam Detection yesterday, Google is now rolling out Loss of Pulse Detection in the US.
Context & Ripple Effects
Google’s US deployment follows its February FDA clearance announcement, while the feature had already reached European Pixel Watch 3 users in 2024. It turns a regulatory milestone into an available product capability for the company’s US wearable customers.
The release extends a safety-feature arc that includes fall detection reaching all Pixel Watch users and later Pixel Watch health monitoring additions. It also arrives through the same update cadence as Google’s recent Scam Detection rollout.
First-order effects
- US Pixel Watch 3 users can now receive Loss of Pulse Detection through Google’s OTA rollout, subject to the feature’s availability on their device.
- Google converts FDA clearance into a US-facing Pixel Watch 3 safety capability, bringing the market in line with the earlier European rollout.
Second-order effects
- The addition makes the Pixel Watch 3’s safety package more comprehensive alongside Google’s existing fall-detection and health-monitoring features, strengthening the value of software updates for current owners.
- Google’s deployment ties the timing of US health-safety features to regulatory clearance, making approval-to-rollout execution a visible part of its wearable product cycle.
Third-order effects
- If this rollout pattern continues, wearable competition will increasingly hinge on the ability to pair sensors and software with region-specific regulatory pathways, rather than hardware releases alone.
- The story points toward health and personal-safety functions becoming a recurring, post-purchase differentiator for connected devices, though the pace of expansion will remain constrained by clearance and rollout requirements.
The trend: Wearable makers are turning regulated safety and health capabilities into software-delivered product differentiation across markets.